Pioneers in Scalp Cooling

We work alongside medical experts, professionals and world leaders in the field to provide extensive research, clinical studies and testing. Independent observational studies have demonstrated the safety and effectiveness of the Paxman Scalp Cooling System in the prevention of chemotherapy induced hair loss with widely used chemotherapy dosages and regimens.

All trials have reported high levels of patient comfort and acceptability, with low numbers of patients discontinuing scalp cooling. Our clinical efficacy brochure details the proven performance in five different studies carried out using the Paxman Scalp Cooling System.  see more

Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.  see more

Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.  see more

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis  see more

Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.see more

Factors Influencing the Effectiveness of Scalp Cooling in the Prevention of Chemotherapy-Induced Alopecia. see more

Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlledclinical trials.  see more

Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.  see more

A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.  see more

Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.  see more

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.  see more